Top Home Health & Hospice Investors of 2023
The deal activity of Home Health & Hospice investors has been on a steady decline over the past two years, ever since reaching its peak in the fourth quarter of 2021. There were 95 reported transactions in the 2023 Home Health & Hospice market, which is a 16% decrease from 2022 when there were 113 deals announced. The sector was impacted by a number of headwinds, such as low wages, rising cost of delivering care, staffing challenges and a fear of violence among home care aides, nurses and therapists. For 2024, home care leaders are looking toward AI, alternative payer sources, employee-centric solutions and much more so they can provide an integrated and individualized care plan to... Read More »
Healthcare M&A Volume Falls in Q4:23, According to Acquisition Data from LevinPro HC
Health care merger and acquisition activity declined in the fourth quarter of 2023, dropping to 493 deals, according to new acquisition data from LevinPro HC. Activity in the fourth quarter was 4% lower than in the third quarter of 2023, when 511 transactions were announced. Compared with the fourth quarter of 2022, activity fell 13% in the fourth quarter. The slowdown was felt across each healthcare vertical. Activity in sectors such as Physician Medical Groups saw significant declines in M&A volume, with 103 deals, an 18% decrease compared to the previous quarter. Demand for healthcare real estate, such as medical office buildings and properties, has driven high deal volume in the... Read More »
Headwinds Take Toll on Q4 and FY 2023 Healthcare M&A
Fourth Quarter Results If we had to judge healthcare M&A activity in the fourth quarter of 2023, we’d say it was “fine.” Volume reached 489 deals, the slowest quarter of the past two years, but considering the macroeconomic headwinds the industry faced in 2023, activity could have been much slower. Deal activity in the fourth quarter of 2023 was 4% lower than volume in the third quarter and 14% down from Q4:22. In 2022, the quarterly M&A activity averaged 610 deals, but that fell to 538 in 2023, and with headwinds remaining essentially unchanged, we expect 2024 to keep that trend. Dealmaking remained relatively stable in the fourth quarter due to another wave of private equity... Read More »
2023 Performance Snapshot of Home Health and Hospice Leaders
Explore the financial performance of key players in the Home Health and Hospice (HH&H) sector during 2023. From Amedisys’ steady growth to Addus’ fluctuations, discover the ups and downs, strategic moves and investor interest that defined the industry. 2023 Quarterly Stock Performance of Publicly Traded HH&H Companies: CompanyQ1 2023Q2 2023Q3 2023Q4 2023Amedisys$73.55 $91.44 $93.40 $95.06 Encompass Health$54.10 $67.71 $67.16 $66.72 The Pennant Group$14.28 $12.28 $11.13 $13.92 Addus HomeCare$106.76 $92.70 $85.19 $92.85 Enhabit$13.91 $11.50 $11.25 $10.35 Aveanna... Read More »
Navigating Digital Health in 2024: Insights from Rock Health
Rock Health’s “Digital Health at the Turn of 2024” report sheds light on trends shaping the trajectory of the healthcare industry in 2024. Drawing observations from an in-depth analysis of research, funding and partnerships, the report identifies noteworthy developments gaining momentum and facing challenges. AI in Healthcare and Value-Based Care Enablement: While AI in healthcare and value-based care enablement stand as burgeoning trends, the report highlights a current limitation in scalability. The authors emphasize crucial considerations for AI builders, addressing concerns such as algorithm bias and ethical implications. For stakeholders like providers, payers... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
